Bionano Announces Presentation of OGM Utility Across Cancer Genomics Research Applications at the American Association for Cancer Research (AACR) Annual MeetingGlobeNewsWire • 04/13/23
3 Supercharged Growth Stocks With 662% to 741% Upside, According to Wall StreetThe Motley Fool • 04/11/23
Bionano Genomics' cash in SVB accounts represented about 41% of its cash and cash equivalents at yearendMarket Watch • 03/13/23
Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Featuring OGM Utility Across a Broad Range of Research ApplicationsGlobeNewsWire • 03/13/23
Bionano Genomics, Inc. (BNGO) Reports Q4 Loss, Misses Revenue EstimatesZacks Investment Research • 03/10/23
Bionano Genomics, Inc. (BNGO) Presents at Cowen 43rd Annual Healthcare Conference (Transcript)Seeking Alpha • 03/06/23
This Growth Stock Is Down 38% and Wall Street Says It's Worth Buying Hand Over FistThe Motley Fool • 03/02/23
Analysts Estimate Bionano Genomics, Inc. (BNGO) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 02/28/23
Get Ready to Soar: 2 High-Octane Growth Stocks Wall Street Expects to Climb in 2023The Motley Fool • 02/28/23
Bionano Announces China NMPA Approval for DNA Extraction and Labeling Products for IVD Use in Hematologic MalignanciesGlobeNewsWire • 02/22/23
Bionano Shares Overview of AGBT Pre-Conference Workshop Program Along with Details of Company's Innovative Research Grant OpportunityGlobeNewsWire • 02/14/23
Is Bionano Genomics (BNGO) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 02/13/23
Why Bionano Genomics, Pacific Biosciences of California, and Sangamo Therapeutics Stocks Crumbled This WeekThe Motley Fool • 02/10/23